Extended Bile Duct Resection Liver and Transplantation in Patients with Hilar Cholangiocarcinoma: Long-Term Results

被引:45
|
作者
Seehofer, Daniel [1 ]
Thelen, Armin
Neumann, Ulf P.
Veltzke-Schlieker, Winfried [2 ]
Denecke, Timm [3 ]
Kamphues, Carsten
Pratschke, Johann
Jonas, Sven
Neuhaus, Peter
机构
[1] Charite Campus Virchow, Dept Gen Visceral & Transplantat Surg, D-13353 Berlin, Germany
[2] Charite Campus Virchow, Dept Gastroenterol & Hepatol, D-13353 Berlin, Germany
[3] Charite Campus Virchow, Dept Radiol, D-13353 Berlin, Germany
关键词
SINGLE-CENTER EXPERIENCE; PERIHILAR CHOLANGIOCARCINOMA; HEPATOBILIARY MALIGNANCY; SURGICAL-TREATMENT; CARCINOMA; SURVIVAL; TUMORS; PREDICTORS; RECURRENCE; DISEASE;
D O I
10.1002/lt.21887
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
For patients with irresectable hilar cholangiocarcinoma, liver transplantation (LT) is currently being reassessed because of promising data for neoadjuvant radiochemotherapy. For increased radicality, hepatectomy in combination with pancreatic head resection [extended bile duct resection (EBDR)] was performed for irresectable hilar cholangiocarcinoma during our initial experience. EBDR and LT was performed in 16 patients between 1992 and 1998. No neoadjuvant or adjuvant treatment was performed. The Union Internationale Contre le Cancer stages were I (n = 6), IIA (5), IIB (3), and IV (2). To evaluate the suspected increase in surgical radicality, a matched pair analysis was performed with 8 patients undergoing LT for hilar cholangiocarcinoma without partial pancreatoduodenectomy. The 1-, 5-, and 10-year patient survival rates after EBDR were 63%, 38%, and 38%, respectively. Twelve patients died: 2 died because of postoperative complications, 8 died because of tumor recurrence, and 2 died while recurrence-free more than 10 years after transplantation. Among the 6 stage I patients, only 1 developed tumor recurrence, but 2 died because of postoperative complications. The following factors showed a trend toward inferior survival: distant metastases, positive lymph nodes, high carbohydrate antigen 19-9 levels, and preoperative percutaneous transhepatic cholangiodrainage. When all lymph node-negative patients were considered after the exclusion of perioperative deaths, 10-year survival was 56%. In conclusion, the overall long-term survival was relatively low in our inhomogeneous cohort but favorable in patients without metastases. However, because of the increased perioperative mortality, EBDR is not recommended as a standard procedure for hilar cholangiocarcinoma instead of LT alone. To further improve the results, other approaches such as (neo)adjuvant therapy have to be increasingly investigated. Liver Transpl 15: 1499-1507, 2009. (C) 2009 AASLD.
引用
收藏
页码:1499 / 1507
页数:9
相关论文
共 50 条
  • [31] Extensive hilar bile duct resection using a transhepatic approach for patients with hepatic hilar bile duct diseases
    Miyazaki, Masaru
    Kimura, Fumio
    Shimizu, Hiroaki
    Yoshidome, Hiroyuki
    Otsuka, Masayuki
    Kato, Atsushi
    Hideyuki, Yoshitomi
    Nozawa, Satoshi
    Furukawa, Katsunori
    Mituhashi, Noboru
    Takeuchi, Dan
    Suda, Kousuke
    Takano, Shigetsugu
    AMERICAN JOURNAL OF SURGERY, 2008, 196 (01): : 125 - 129
  • [32] Long-term outcome and prognostic factors of patients with hilar cholangiocarcinoma
    Andreas Weber
    Sonja Landrock
    Jochen Schneider
    Manfred Stangl
    Bruno Neu
    Peter Born
    Meinhard Classen
    Thomas Rsch
    Roland M Schmid
    Christian Prinz
    World Journal of Gastroenterology, 2007, (09) : 1422 - 1426
  • [33] Long-term outcome and prognostic factors of patients with hilar cholangiocarcinoma
    Weber, Andreas
    Landrock, Sonja
    Schneider, Jochen
    Stangl, Manfred
    Neu, Bruno
    Born, Peter
    Classen, Meinhard
    Roesch, Thomas
    Schmid, Roland M.
    Prinz, Christian
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (09) : 1422 - 1426
  • [34] Conditional Survival Probability of Long-term Survival After Resection of Hilar Cholangiocarcinoma
    Buettner, S.
    Margonis, G.
    Kim, Y.
    Ethun, C. G.
    Maithel, S. K.
    Poultsides, G. A.
    Tran, T.
    Idrees, K.
    Isom, C. A.
    Fields, R. C.
    Krasnick, B. A.
    Weber, S.
    Salem, A. I.
    Martin, R. C.
    Scoggins, C.
    Shen, P.
    Mogal, H.
    Schmidt, C. R.
    Beal, E. W.
    Hatzaras, I.
    Shenoy, R.
    Pawlik, T. M.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S107 - S107
  • [35] Perioperative Blood Transfusion and Long-Term Outcomes After Resection of Hilar Cholangiocarcinoma
    Yi-Nan Shen
    Han Zhang
    Jun-Hua Lu
    Myron E. Schwartz
    Tian Yang
    Journal of Gastrointestinal Surgery, 2015, 19 : 1192 - 1193
  • [36] Perioperative Blood Transfusion and Long-Term Outcomes After Resection of Hilar Cholangiocarcinoma
    Shen, Yi-Nan
    Zhang, Han
    Lu, Jun-Hua
    Schwartz, Myron E.
    Yang, Tian
    JOURNAL OF GASTROINTESTINAL SURGERY, 2015, 19 (06) : 1192 - 1193
  • [37] Looking Forward: Surgical Resection, Liver Transplantation, and Hilar Cholangiocarcinoma
    Caroline C. Jadlowiec
    Julie K. Heimbach
    Current Hepatology Reports, 2016, 15 (4) : 317 - 322
  • [38] Outcomes of Surgical Resection versus Liver Transplantation in Hilar Cholangiocarcinoma
    White, M. K.
    Aucejo, F.
    Moro, A.
    Sasaki, K.
    Stephans, K.
    Estfan, B.
    Quintini, C.
    Eghtesad, B.
    Hashimoto, K.
    Masato, F.
    Miller, C.
    Menon, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 771 - 771
  • [39] Comparative Analysis of Resection and Liver Transplantation for Intrahepatic and Hilar Cholangiocarcinoma
    Hong, Johnny C.
    Jones, Christopher M.
    Duffy, John P.
    Petrowsky, Henrik
    Farmer, Douglas G.
    French, Samuel
    Finn, Richard
    Durazo, Francisco A.
    Saab, Sammy
    Tong, Myron J.
    Hiatt, Jonathan R.
    Busuttil, Ronald W.
    ARCHIVES OF SURGERY, 2011, 146 (06) : 683 - 689
  • [40] Unsatisfactory Long-term Results of Liver Transplant in Patients With Intrahepatic Cholangiocarcinoma
    Krasnodebski, Maciej
    Grat, Michal
    Jastrzebski, Maciej
    Szczesniak, Michalina
    Morawski, Marcin
    Zajac, Krzysztof
    Patkowski, Waldemar
    Zieniewicz, Krzysztof
    TRANSPLANTATION PROCEEDINGS, 2020, 52 (08) : 2463 - 2467